FDA Authorizes Change in How Monkeypox Vaccine Is Given, Stretching Supply Amid High Demand
The US Food and Drug Administration issued an emergency use authorization Tuesday that allows healthcare providers to change how the Jynneos monkeypox vaccine is administered, stretching out the supply amid high demand.
The vaccine can now be given to high-risk adults intradermally, meaning between the layers of the skin, rather than subcutaneously, or under the skin, as it has been given up till now. This will allow providers to get five doses out of a standard one-dose vial.
The new EUA also allows subcutaneous vaccination in people under 18 who are at high risk of infection ...